We found that GLS1 levels increased in both patients and in an animal model for NASH, and that this was dependent on fibrosis, suggesting that GLS1 may enhance glutaminolysis associated with hypoxia-induced HIF-2α (37, 65). The gene discussed is EPAS1; the disease is metabolic dysfunction-associated steatohepatitis.